Tailoring Colorectal Cancer Treatment: Sidedness, Biomarkers (BRAF, HER2) and Beyond
In this webinar, Dr. Kanwal Raghav spent the hour diving into the research behind two biomarkers related to colorectal cancer: HER2 and Sidedness. In this informative session, we learn about these biomarkers that researchers are studying, as they may affect your treatment plan. Knowing your biomarkers will allow you to be your own best advocate.
Watch the Webinar on YouTube
View the Slides on Slideshare
Other Resources Regarding Tailoring Colorectal Cancer Treatment
About the Presenter
Kanwal P.S. Raghav, MBBS, MD
Dr. Raghav is an Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology in the Division of Cancer Medicine at The University of Texas M.D. Anderson Cancer Center, Houston, TX. He has received a number of honors and awards as a researcher including SWOG Young Investigator Award, Southwest Oncology Group, ASCO & Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology & Conquer Cancer Foundation, and others.